Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,176–5,200 of 7,816 matching trials · page 208 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Bibliotherapy for Improving Caregiving Appraisal Among Informal Caregivers of People With Dementia: A Pilot RCT NCT03852121 Bibliotherapy Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 60 | The Hong Kong Polytechnic University OTHER |
2020-10-19 |
|
Factors Influencing the Deterioration From Cognitive Decline of Normal Aging to Dementia Among Nursing Home Residents NCT04589637 Runs in: Jordan · 1 site |
NA other |
COMPLETED | 182 | Jordan University of Science and Technology OTHER |
2020-10-19 |
|
BABEL Advance Care Planning in Long-term Care NCT03649191 The BABEL Approach to Advance Care Planning in Nursing Homes; Contr... Runs in: Canada · 3 sites |
NA other |
COMPLETED | 713 | University of Manitoba OTHER |
2020-10-14 |
|
Single Dose Study of ALZ-801 Prototype Tablets NCT04585347 ALZ-801 170 mg Fasting; ALZ-801 205 mg Fasting; ALZ-801 205 mg Afte... |
PHASE1 anti-amyloid-aggregation |
COMPLETED | 12 | Alzheon Inc. INDUSTRY |
2020-10-14 |
|
Pragmatic Trial of Video Education in Nursing Homes NCT02612688 ACP Video Program Runs in: United States · 2 sites |
NA other |
COMPLETED | 197,692 | Brown University OTHER |
2020-10-12 |
|
A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier. NCT01924858 GSK2647544 oral; [18F]GSK2647544 IV bolus Runs in: United Kingdom · 1 site |
PHASE1 other |
TERMINATED | 4 | GlaxoSmithKline INDUSTRY |
2020-10-09 |
|
IntelliCare in College Students NCT04035577 Mobile self-help intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Northwestern University OTHER |
2020-10-08 |
|
Optimizing a Smartphone Application for Individuals With Eating Disorders NCT02503098 Recovery Record adaptive smartphone application; Recovery Record st... Runs in: United States · 2 sites |
NA other |
COMPLETED | 3,340 | Recovery Record Research INDUSTRY |
2020-10-06 |
|
Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia) NCT03160027 Vielight Neuro Gamma Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | University of California, San Francisco OTHER |
2020-10-06 |
|
Brain-Health Lifestyle Restructuring Intervention NCT04576624 Lifestyle Intervention; social activity Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 125 | National Cheng Kung University OTHER |
2020-10-06 |
|
A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine NCT03560245 Bryostatin; Placebo Runs in: United States · 28 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 108 | Neurotrope Bioscience, Inc. INDUSTRY |
2020-10-01 |
|
Expanded Access to Provide SUVN-502 for the Treatment of Subjects With Alzheimer's Disease NCT03564964 SUVN-502 |
NA other |
NO_LONGER_AVAILABLE | — | Suven Life Sciences Limited INDUSTRY |
2020-09-29 |
|
Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms in Home Care Services NCT04034680 TIME; Education-only intervention Runs in: Norway · 1 site |
NA other |
COMPLETED | 40 | Sykehuset Innlandet HF OTHER |
2020-09-29 |
|
Arterial Spin Labeling (ASL) MRI for Cognitive Decline NCT01727622 FDG-PET; ASL-MRI; Lumbar Puncture Runs in: United States · 1 site |
NA other |
COMPLETED | 102 | University of Pennsylvania OTHER |
2020-09-28 |
|
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis NCT01083316 Bortezomib; Dexamethasone; Melphalan Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 35 | Boston Medical Center OTHER |
2020-09-25 |
|
Flortaucipir PET Imaging in Subjects With FTD NCT03040713 Flortaucipir F18; Brain PET scan Runs in: United States · 3 sites |
PHASE1 other |
COMPLETED | 16 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-25 |
|
Changes in the Perception of Personal Dignity Over the Course of Dementia NCT04443621 questionnaire; in-depth interview Runs in: Czechia · 5 sites |
NA other |
UNKNOWN | 500 | Palacky University OTHER |
2020-09-25 |
|
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease NCT04468347 Flortaucipir F18; Brain PET scan |
PHASE1 other |
COMPLETED | 89 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-25 |
|
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects NCT04474405 Flortaucipir F18; Brain PET Scan; Whole body PET scan; Florbetapir ... Runs in: United States · 2 sites |
EARLY_PHASE1 other |
COMPLETED | 36 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-25 |
|
Repetitive Transcranial Magnetic Stimulation With H-coil in Alzheimer's Disease NCT04562506 rTMS with H-coil; Sham rTMS stimulation with H-coil Runs in: Italy · 1 site |
NA other |
COMPLETED | 30 | Giancarlo Comi OTHER |
2020-09-24 |
|
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects NCT02016560 florbetapir F 18; Flortaucipir F18; Brain PET Scan Runs in: United States · 27 sites |
PHASE2|PHASE3 other |
COMPLETED | 383 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-22 |
|
F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis NCT02414230 Drug: F 18 T807 Runs in: United States · 1 site |
NA other |
COMPLETED | 9 | Tammie L. S. Benzinger, MD, PhD OTHER |
2020-09-22 |
|
F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected NCT03279523 F 18 T807 Runs in: United States · 1 site |
NA other |
COMPLETED | 60 | Tammie L. S. Benzinger, MD, PhD OTHER |
2020-09-22 |
|
Tricaprilin in Mild to Moderate Alzheimer's Disease NCT00142805 Tricaprilin; Placebo Runs in: United States · 25 sites |
PHASE2 other |
COMPLETED | 152 | Cerecin INDUSTRY |
2020-09-21 |
|
Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK) NCT04555629 Advanced Cognitive Stimulation Therapy Hong Kong |
NA other |
UNKNOWN | 32 | University College, London OTHER |
2020-09-21 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial